NASDAQ:MDWD

Mediwound Stock News

Healthcare > Biotechnology

Buy MDWD

*Your capital is at risk

$14.12

+0.0200 (+0.142%)

At Close: Jul 31, 2026

Vericel Analyst Projects Wound Care Product Sales Will Grow Fivefold By 2025

07:09pm, Wednesday, 09'th Oct 2019

Vericel Corp (NASDAQ: VCEL ), a commercial-stage company that specializes in advanced cell therapies for treating patients with knee cartilage defects and severe burn wounds, is investment-worthy, acc

Vericel And MediWound Announce Initiation Of US NexoBrid Expanded Access Treatment Protocol

12:00am, Wednesday, 02'nd Oct 2019

MediWound Ltd. (MDWD) CEO Sharon Malka on Q2 2019 Results - Earnings Call Transcript

12:00am, Tuesday, 13'th Aug 2019

MediWound Q2 EPS $(0.12) Misses $(0.03) Estimate, Sales $20.7M Do Not Compare to $4.45M Estimate

12:00am, Monday, 12'th Aug 2019

70 Biggest Movers From Yesterday

12:00am, Tuesday, 06'th Aug 2019

H.C. Wainwright Initiates Coverage On MediWound with Buy Rating, Announces $5.5 Price Target

12:00am, Monday, 05'th Aug 2019

Stocks That Set New 52-Week Lows Friday Morning

12:00am, Friday, 02'nd Aug 2019

Stocks that Reached Yearly Lows Thursday Morning

12:00am, Thursday, 01'st Aug 2019

42 Stocks Moving In Wednesday's Pre-Market Session

12:00am, Wednesday, 31'st Jul 2019

Will MediWound (MDWD) Report Negative Q2 Earnings? What You Should Know

12:00am, Tuesday, 30'th Jul 2019

64 Biggest Movers From Yesterday

12:00am, Friday, 26'th Jul 2019

50 Biggest Movers From Yesterday

12:00am, Thursday, 25'th Jul 2019

MediWound Launches EscharEx US Clinical Development Program

12:00am, Monday, 22'nd Jul 2019

41 Stocks Moving In Friday's Mid-Day Session

12:00am, Friday, 19'th Jul 2019

60 Biggest Movers From Yesterday

12:00am, Tuesday, 25'th Jun 2019

Mediwound Stock News

Vericel Analyst Projects Wound Care Product Sales Will Grow Fivefold By 2025

Vericel And MediWound Announce Initiation Of US NexoBrid Expanded Access Treatment Protocol

MediWound Ltd. (MDWD) CEO Sharon Malka on Q2 2019 Results - Earnings Call Transcript

MediWound Q2 EPS $(0.12) Misses $(0.03) Estimate, Sales $20.7M Do Not Compare to $4.45M Estimate

70 Biggest Movers From Yesterday

H.C. Wainwright Initiates Coverage On MediWound with Buy Rating, Announces $5.5 Price Target

Stocks That Set New 52-Week Lows Friday Morning

Stocks that Reached Yearly Lows Thursday Morning

42 Stocks Moving In Wednesday's Pre-Market Session

Will MediWound (MDWD) Report Negative Q2 Earnings? What You Should Know

64 Biggest Movers From Yesterday

50 Biggest Movers From Yesterday

MediWound Launches EscharEx US Clinical Development Program

41 Stocks Moving In Friday's Mid-Day Session

60 Biggest Movers From Yesterday

Top Fintech Company